Published Date: 08 Mar 2023
A group of scientists led by Dr. Yamin Zhang and Dr. Colin Franz of Shirley Ryan AbilityLab and Dr. John Rogers of Northwestern University have developed a new technique. Change...
Read Full NewsPolverino stresses the need for prospective analysis to validate CC16 and mucus plugs as viable biomarkers for COPD status.
In a recently published study, integrating prehospital GFAP measurements with established stroke scales significantly improved the accuracy of large vessel occlusion detection in patients with acute stroke.
Here's some of what is coming soon to NeurologyLive® this week.
Inside MS: A Clinician's Compass, a podcast hosted by neuroimmunologist Lindsay Ross, MD, brings you an exclusive interview with Edith Graham, MD. [LISTEN TIME: 40 minutes]
Sands explains the potential benefits of obefazimod and reviews findings from ABTECT 1 and ABTECT 2 presented at ACG 2025.
In this end-of-year reel, HCPLive has showcased several key highlights from the Skin of Color Savvy podcast in 2025.
This episode of Skin of Color Savvy was filmed on-site at the Skin of Color Society's 'Meeting the Challenge Summit' in Washington, DC.
1.
UK study evaluates effectiveness of cancer diagnosis pathway for patients with non-specific symptoms
2.
New target points to combination therapy for thwarting multidrug resistance in cancer treatment
3.
Data-driven risk stratification guides childhood brain tumor treatment, reducing side effects
4.
An Examine More Into the Acceptance of CRISPR/Cas9 Gene Therapy for Sickle Cell Illness.
5.
Disparities in use of MRI to detect prostate cancer: Race and location may influence testing
1.
Landmark Medical Oncology Trials Redefining Early Breast Cancer Management
2.
Digital Oncology: How Remote Monitoring and Mobile Health Are Transforming Cancer Care
3.
Case Study: Personalized Medicine Based on Genetic Profiling in Oncology
4.
Hepatocellular Carcinoma: Progress in Detection, Pathogenesis, and Treatment
5.
Understanding Extramammary Paget's Disease: Causes, Symptoms and Treatment Options
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part XII
2.
Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC
3.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part I
4.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
5.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation